Epidemiology of multimorbidity associated with atherosclerotic cardiovascular disease in the United States, 1999–2018
Authors:
Open Access
- 23 January 2024
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 1-13
Abstract
Background: The multimorbidity of Atherosclerotic cardiovascular disease (ASCVD) and many other chronic conditions is becoming common. This study aimed to assess multimorbidity distribution in ASCVD among adults in the United States from 1999 to 2018. Methods: This cross-sectional survey from the National Health and Nutrition Examination Survey (NHANES) 1999–2018 using stratified multistage probability design. Among the 53,083 survey respondents during the study period, 5,729 US adults aged ≥ 20 years with ASCVD. Joinpoint regression was used to assess the statistical significance of prevalence trends in the prevalence of ASCVD stratified by multimorbidity. The Apriori association rule mining algorithm was used to identify common multimorbidity association patterns in ASCVD patients. Results: Overall, 5,729 of 53,083 individuals had ASCVD, and the prevalence showed a slow declining trend (biannual percentage change = -0.81%, p = 0.035, average 7.71%). The prevalence of ASCVD significantly decreased in populations without dyslipidemia, diabetes mellitus (DM), hypertension, asthma, chronic obstructive pulmonary disease (COPD), and arthritis (all groups, p < 0.05). Additionally, 65.6% of ASCVD patients had at least four of the 12 selected chronic conditions, with four and five being the most common numbers of conditions (17.9% and 17.7%, respectively). The five most common chronic conditions were (in order) dyslipidemia, hypertension, arthritis, chronic kidney disease, and DM. The coexistence of hypertension and dyslipidemia had the highest support in association rules (support = 0.63), while the coexistence of dyslipidemia, hypertension, metabolic syndrome, and DM had the highest lift (lift = 1.82). Conclusions: During the 20-year survey period, there was a significant decrease in the overall prevalence of ASCVD. However, this reduction was primarily observed in individuals without dyslipidemia, DM, hypertension, asthma, COPD, and arthritis. Among populations with any of the evaluated chronic conditions, the prevalence of ASCVD remained unchanged. Most of ASCVD patients had four or more concurrent chronic conditions.Keywords
This publication has 27 references indexed in Scilit:
- Patterns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: A population-based cohort studyPLOS Medicine, 2018
- Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational studyBMC Cardiovascular Disorders, 2017
- Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of PhysiciansAnnals of Internal Medicine, 2017
- Comorbidities and characteristics of coronary heart disease patients: their impact on health-related quality of lifeHealth and Quality of Life Outcomes, 2016
- Magnitude and Impact of Multimorbidity on Clinical Outcomes in Older Adults with Cardiovascular DiseaseClinics in Geriatric Medicine, 2016
- Epidemiology of Multimorbidity in Older Adults with Cardiovascular DiseaseClinics in Geriatric Medicine, 2016
- AHA/ACC/HHS Strategies to Enhance Application of Clinical Practice Guidelines in Patients With Cardiovascular Disease and Comorbid ConditionsJACC, 2014
- IOM and DHHS Meeting on Making Clinical Practice Guidelines Appropriate for Patients with Multiple Chronic ConditionsThe Annals of Family Medicine, 2014
- Defining and Measuring Chronic Conditions: Imperatives for Research, Policy, Program, and PracticePreventing Chronic Disease, 2013
- Permutation tests for joinpoint regression with applications to cancer ratesStatistics in Medicine, 2000